While THC and CBD have been the most widely-known cannabinoids in the cannabis industry, dozens of other phytocannabinoids are found in cannabis plants.
One of these is Cannabichromene (CBC). It may not be as well-known as THC and CBD, but CBC has been linked to pain relief, inflammation, and even neurogenesis, which is the ability to create new brain cells.
It’s Effective for Pain
Pain is a common issue that can make life difficult for individuals. Fortunately, cannabis can offer pain relief in many cases. It is commonly known to provide analgesic effects similar to those of prescription narcotics without the adverse side effects of these drugs.
CBC may also help with chronic pain by reducing inflammation. This is thanks to its affinity for the transient receptor potential cation channel (TRPV1).
Researchers have found that CBC interacts with multiple targets involved in pain control at the spinal level, and it is non-psychoactive, making it an attractive alternative to opiates.
It is also believed to encourage the growth of new brain cells, which could provide neuroprotective benefits. Therefore, it is unsurprising that buying cannabichromene wholesale could effectively treat various conditions, including depression and anxiety. It is an important phytocannabinoid that deserves further study to determine its full effects.
It’s Effective for Inflammation
CBC naturally develops from the same chemical substance in cannabis plants that produce THC and CBD, called cannabigerol acid (CBGA). Unlike THC, which has a poor binding affinity to CB1 receptors in the brain, CBC is a potent agonist at CB2 receptors throughout the body.
In addition to lowering edema and inflammation, CBC also suppresses lipid production in sebaceous glands, which helps to prevent the development of acne. It also promotes the production of endocannabinoids, natural compounds that help balance our body’s chemistry.
A new study has revealed that several non-psychoactive cannabinoids and terpenes effectively reduce inflammation. The findings suggest that these compounds could provide an alternative to traditional anti-inflammatory medications, which have a high risk of side effects.
It’s Effective for Depression
An estimated 17 million Americans suffer from depression – a chronic condition affecting every aspect of their life, from their relationships to their ability to work. Treatment for mild cases of depression can be successful with psychotherapy (also referred to as “talk therapy”).
SSRIs and other prescription drugs are often the most effective way to treat depressive disorders but they have many side effects. Marijuana offers a more natural approach to treating this illness and can be used in various ways.
One study found that CBC can help promote neurogenesis, the new brain cell formation process. It may also help treat a wide range of neurodegenerative diseases, including Alzheimer’s and Parkinson’s.
CBC is one of the more mysterious cannabinoids. It doesn’t interact directly with the CB1 receptors that produce the psychoactive effect associated with THC and CBD or with the CB2 receptors that regulate pain and inflammation throughout the body. However, it’s known to work with THC and other cannabinoids to increase the “entourage” effect that gives medical cannabis its therapeutic benefits.
It’s Effective for Anxiety
Anxiety is a common chronic condition that can be debilitating to people of all ages. It can also be a side effect of some medications. Symptoms range from mild anxiety in everyday life to severe panic attacks and fear of the future.
An estimated 3.5 million people in the United States are diagnosed with anxiety, and 2.4 million receive pharmacological treatment. Clinicians often manage stress by prescribing benzodiazepines, antidepressants, and antipsychotics to help patients return to their everyday lives.
Anxiety is one of the most common conditions for which people use medical cannabis. It is the second most common reason for prescription in Australia and is being treated with both D9-tetrahydrocannabinol (THC)-containing and cannabidiol (CBD)-dominant products.